![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AIM 01 September 2009 ? NOTICE (614) 01/09/2009 7:00am CANCELLATION OF ADMISSION OF SECURITIES TO TRADING ON AIM YORK PHARMA PLC Trading on AIM for the under-mentioned securities have been...
Could not retrieve article
ULURU 27 July 2009 ? ULURU NEWS Contact: Company Renaat E. Van den Hooff President & CEO Terry K. Wallberg Vice President & CFO (214) 905-5145 ULURU INC. STATEMENT OF INTENTION...
York Pharma plc 22 July 2009 ? York Pharma plc ("York" or the "Company") Update on Uluru Loan Repayment On 7 April 2009, York Pharma plc announced that Uluru, Inc. ("Uluru") had made...
York Pharma plc 25 June 2009 ? 25 June 2009 York Pharma plc ("York" or the "Company") Directorate change York today announces that it has mutually agreed terms for the departure of Terry...
York Pharma plc 24 June 2009 ? York Pharma plc ("York" or the "Company") Update on merger discussions The Board of York today announces that the discussions between the Company and ULURU...
York Pharma plc 17 June 2009 ? + + | TR-1:NOTIFICATION OF MAJOR INTERESTS IN SHARES | + + + + + + + | 1. Identity of the issuer or the | York Pharma plc | | underlying issuer | | | of...
York Pharma plc 12 May 2009 ? 12 May 2009 York Pharma plc (YRK.L) ("York" or the "Company") Restructure update and divestment of French subsidiary In January 2009, York announced that its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions